Buy One Get One free -Llimited Time Offer X
Resplend, a prescription drug, is manufactured in various forms such as Tablet. It is typically used for the treatment of High BP. Other than this, Resplend has some other therapeutic uses, which have been discussed ahead.
The right dosage of Resplend depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. This information has been provided in detail in the dosage section.
Common side effects of Resplend include Fainting. Some other side effects of Resplend have been listed ahead. These side effects of Resplend are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Resplend's effect is Severe during pregnancy and Severe for lactating mothers. Warnings related to Resplend's effects on the liver, heart and kidney, if any, have been listed below.
Resplend is contraindicated in people with pre-existing medical conditions like Low Blood Pressure (Hypotension), Angina as it can result in adverse effects. Some other conditions that can be affected by Resplend are listed in the contraindications section below.
Drug interactions for Resplend have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Resplend, it is important to know that it is not safe while driving, and is not habit-forming.
Resplend is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Resplend is used -
Moderate
Mild
Common
Is the use of Resplend safe for pregnant women?
Resplend has many dangerous side effects in pregnant women. If you are pregnant, do not consume Resplend without medical advice.
Is the use of Resplend safe during breastfeeding?
Resplend may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Resplend on the Kidneys?
Resplend does not damage the kidneys.
What is the effect of Resplend on the Liver?
Very few cases of side effects of Resplend on the liver have been reported.
What is the effect of Resplend on the Heart?
Resplend is rarely harmful for the heart.
Resplend should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Resplend unless your doctor advises you to do so -
Is this Resplend habit forming or addictive?
Resplend does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Resplend you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Resplend is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Resplend is unable to treat or cure mental disorders.
Interaction between Food and Resplend
There isn't any research available on the side effects of taking Resplend with food.
Interaction between Alcohol and Resplend
Taking alcohol with Resplend can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Minipress® (prazosin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1046-1047